1Lankat-Buttgereit B, Tampe R. The transporter associated with antigen processing: function and implications in human diseases [J]. Physiol Rev, 2002, 82(1): 187-204.
2Vambutas A, Bonagura VR, Steinberg BM. Altered expression of TAP-1 and major histocompatibility complex class I in laryngeal papillomatosis: correlation of TAP-1 with disease[J]. Clin Diagn Lab Immunol, 2000, 7(1): 79-85.
3Evans M, Borysiewicz LK, Evans AS, et al. Antigen processing defects in cervical carcinomas limit the presentation of a CTL epitope from human papillomavirus 16 E6[J]. J Immunol, 2001,167(9): 5420-5428.
4Powis SJ, Deverson EV, Coadwell WJ, et al. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule[J]. Nature, 1992, 357(6375): 211-215.
5Vambutas A, Bonagura VR, Steinberg BM. Altered expression of TAP1 and major histocompatibility complex class I in laryngeal papillomatosis : correlation of TAPI with disease. Clin Diagn Lab Immunol 2000; 7 : 79 - 85.
6Arany Z, Yen A, Tyring SK. P53, WAF/CIPI and mdm2 expression in skin lesions associated with human papillomavirus and human immunodefieieney vires. Antieaneer Res 1997 ; 17 : 1281 - 1285.
7Zhu K, Wang J, Zhu J, et al. P53 induces TAPI and enhances the transport of MHC class I peplides. Oncogene 1999; 18:7740 -7747.
